"Administering MMR Vaccine". Centers for Disease Control and Prevention. 26 January 2021. Archived from the original on 28 December 2021. Retrieved 28 December 2021.
Centers for Disease Control and Prevention (CDC) (December 2006). "Measles--United States, 2005"(PDF). MMWR. Morbidity and Mortality Weekly Report. 55 (50): 1348–1351. PMID17183226. Archived(PDF) from the original on 26 January 2021. Retrieved 26 January 2020.
Goodson JL, Seward JF (December 2015). "Measles 50 Years After Use of Measles Vaccine". Infectious Disease Clinics of North America. 29 (4): 725–743. doi:10.1016/j.idc.2015.08.001. PMID26610423.
Vesikari T, Sadzot-Delvaux C, Rentier B, Gershon A (July 2007). "Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine". The Pediatric Infectious Disease Journal. 26 (7): 632–638. doi:10.1097/INF.0b013e3180616c8f. PMID17596807. S2CID41981427.
Schattner A (June 2005). "Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines". Vaccine. 23 (30): 3876–3886. doi:10.1016/j.vaccine.2005.03.005. PMID15917108.
The Editors of The Lancet (February 2010). "Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children". Lancet. 375 (9713): 445. doi:10.1016/S0140-6736(10)60175-4. PMID20137807. S2CID26364726.
Godlee F, Smith J, Marcovitch H (January 2011). "Wakefield's article linking MMR vaccine and autism was fraudulent". BMJ. 342 (jan05 1, c7452): c7452. doi:10.1136/bmj.c7452. PMID21209060. S2CID43640126.
Wellington K, Goa KL (2003). "Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella". Drugs. 63 (19): 2107–26. doi:10.2165/00003495-200363190-00012. PMID12962524.
O'Leary ST, Suh CA, Marin M (November 2012). "Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?". Vaccine. 30 (48): 6731–6733. doi:10.1016/j.vaccine.2012.08.075. PMID22975026.
"Measles vaccines: WHO position paper – April 2017". Relevé Épidémiologique Hebdomadaire. 92 (17): 205–227. April 2017. hdl:10665/255149. PMID28459148.
"Measles vaccines: WHO position paper – April 2017". Relevé Épidémiologique Hebdomadaire. 92 (17): 205–227. April 2017. hdl:10665/255149. PMID28459148.
Spencer JP, Trondsen Pawlowski RH, Thomas S (June 2017). "Vaccine Adverse Events: Separating Myth from Reality". American Family Physician. 95 (12): 786–794. PMID28671426.
Goodson JL, Seward JF (December 2015). "Measles 50 Years After Use of Measles Vaccine". Infectious Disease Clinics of North America. 29 (4): 725–743. doi:10.1016/j.idc.2015.08.001. PMID26610423.
Centers for Disease Control and Prevention (CDC) (December 2006). "Measles--United States, 2005"(PDF). MMWR. Morbidity and Mortality Weekly Report. 55 (50): 1348–1351. PMID17183226. Archived(PDF) from the original on 26 January 2021. Retrieved 26 January 2020.
Vesikari T, Sadzot-Delvaux C, Rentier B, Gershon A (July 2007). "Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine". The Pediatric Infectious Disease Journal. 26 (7): 632–638. doi:10.1097/INF.0b013e3180616c8f. PMID17596807. S2CID41981427.
Schattner A (June 2005). "Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines". Vaccine. 23 (30): 3876–3886. doi:10.1016/j.vaccine.2005.03.005. PMID15917108.
The Editors of The Lancet (February 2010). "Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children". Lancet. 375 (9713): 445. doi:10.1016/S0140-6736(10)60175-4. PMID20137807. S2CID26364726.
Godlee F, Smith J, Marcovitch H (January 2011). "Wakefield's article linking MMR vaccine and autism was fraudulent". BMJ. 342 (jan05 1, c7452): c7452. doi:10.1136/bmj.c7452. PMID21209060. S2CID43640126.
Wellington K, Goa KL (2003). "Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella". Drugs. 63 (19): 2107–26. doi:10.2165/00003495-200363190-00012. PMID12962524.
O'Leary ST, Suh CA, Marin M (November 2012). "Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?". Vaccine. 30 (48): 6731–6733. doi:10.1016/j.vaccine.2012.08.075. PMID22975026.
Vesikari T, Sadzot-Delvaux C, Rentier B, Gershon A (July 2007). "Increasing coverage and efficiency of measles, mumps, and rubella vaccine and introducing universal varicella vaccination in Europe: a role for the combined vaccine". The Pediatric Infectious Disease Journal. 26 (7): 632–638. doi:10.1097/INF.0b013e3180616c8f. PMID17596807. S2CID41981427.
The Editors of The Lancet (February 2010). "Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children". Lancet. 375 (9713): 445. doi:10.1016/S0140-6736(10)60175-4. PMID20137807. S2CID26364726.
Godlee F, Smith J, Marcovitch H (January 2011). "Wakefield's article linking MMR vaccine and autism was fraudulent". BMJ. 342 (jan05 1, c7452): c7452. doi:10.1136/bmj.c7452. PMID21209060. S2CID43640126.
"Administering MMR Vaccine". Centers for Disease Control and Prevention. 26 January 2021. Archived from the original on 28 December 2021. Retrieved 28 December 2021.
Centers for Disease Control and Prevention (CDC) (December 2006). "Measles--United States, 2005"(PDF). MMWR. Morbidity and Mortality Weekly Report. 55 (50): 1348–1351. PMID17183226. Archived(PDF) from the original on 26 January 2021. Retrieved 26 January 2020.